The first biochemical and/or molecular defects associated with EDS were shown to result from defects in the primary structure, processing, or modification of the fibrillar procollagen types I, III and V leading to qualitative and/or quantitative changes in these collagen types. This evidence concerns the gene COL1A2 and Ehlers-Danlos syndrome.